<i>In vitro</i> cell model to dilucidate the underlying molecular mechanism associated with ophthalmic manifestation of congenital disorders of glycosylation: studying an ALG2-CDG patient. [PDF]
Cubilla MA +3 more
europepmc +1 more source
Quantitative Assessment of Core Fucosylation for Congenital Disorders of Glycosylation. [PDF]
Wada Y, Kadoya M.
europepmc +1 more source
Outcome of creatine supplementation therapy in phosphoglucomutase-1 deficiency associated congenital disorders of glycosylation: Novel insights. [PDF]
Ambrose A +5 more
europepmc +1 more source
Manifestations and Management of Hepatic Dysfunction in Congenital Disorders of Glycosylation. [PDF]
Johnsen C, Edmondson AC.
europepmc +1 more source
Congenital disorders of glycosylation type 1A associated with cerebral hemorrhagic infarction: illustrative case. [PDF]
Nomura Y +6 more
europepmc +1 more source
A Community-Led Approach as a Guide to Overcome Challenges for Therapy Research in Congenital Disorders of Glycosylation. [PDF]
Francisco R +8 more
europepmc +1 more source
Mapping the diagnostic odyssey of congenital disorders of glycosylation (CDG): insights from the community. [PDF]
Granjo P +10 more
europepmc +1 more source
Electrospray Ionization Mass Spectrometry of Apolipoprotein CIII to Evaluate O-glycan Site Occupancy and Sialylation in Congenital Disorders of Glycosylation. [PDF]
Wada Y, Okamoto N.
europepmc +1 more source
Clinical and biochemical footprints of congenital disorders of glycosylation: Proposed nosology. [PDF]
Ng BG +4 more
europepmc +1 more source
Genetic counseling for congenital disorders of glycosylation (CDG). [PDF]
Weixel T, Wolfe L, Macnamara EF.
europepmc +1 more source

